Melanoblasts Populate the Mouse Choroid Earlier in Development Than Previously Described.


Journal

Investigative ophthalmology & visual science
ISSN: 1552-5783
Titre abrégé: Invest Ophthalmol Vis Sci
Pays: United States
ID NLM: 7703701

Informations de publication

Date de publication:
03 08 2020
Historique:
entrez: 16 8 2020
pubmed: 17 8 2020
medline: 7 1 2021
Statut: ppublish

Résumé

Human choroidal melanocytes become evident in the last trimester of development, but very little is known about them. To better understand normal and diseased choroidal melanocyte biology we examined their precursors, melanoblasts (MB), in mouse eyes during development, particularly their relation to the developing vasculature and immune cells. Naïve B6(Cg)-Tyrc-2J/J albino mice were used between embryonic (E) day 15.5 and postnatal (P) day 8, with adult controls. Whole eyes, posterior segments, or dissected choroidal wholemounts were stained with antibodies against tyrosinase-related protein 2, ionized calcium binding adaptor molecule-1 or isolectin B4, and examined by confocal microscopy. Immunoreactive cell numbers in the choroid were quantified with Imaris. One-way ANOVA with Tukey's post hoc test assessed statistical significance. Small numbers of MB were present in the presumptive choroid at E15.5 and E18.5. The density significantly increased between E18.5 (381.4 ± 45.8 cells/mm2) and P0 (695.2 ± 87.1 cells/mm2; P = 0.032). In postnatal eyes MB increased in density and formed multiple layers beneath the choriocapillaris. MB in the periocular mesenchyme preceded the appearance of vascular structures at E15.5. Myeloid cells (Ionized calcium binding adaptor molecule-1-positive) were also present at high densities from this time, and attained adult-equivalent densities by P8 (556.4 ± 73.6 cells/mm2). We demonstrate that choroidal MB and myeloid cells are both present at very early stages of mouse eye development (E15.5). Although MB and vascularization seemed to be unlinked early in choroidal development, they were closely associated at later stages. MB did not migrate into the choroid in waves, nor did they have a consistent relationship with nerves.

Identifiants

pubmed: 32797202
pii: 2770659
doi: 10.1167/iovs.61.10.33
pmc: PMC7441366
doi:

Substances chimiques

Coloring Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

33

Subventions

Organisme : Cancer Research UK
ID : A15673
Pays : United Kingdom
Organisme : Cancer Research UK
ID : A18277
Pays : United Kingdom

Références

Prog Retin Eye Res. 2013 Jan;32:181-95
pubmed: 23128417
Heredity (Edinb). 2006 Sep;97(3):222-34
pubmed: 16823403
FASEB J. 2019 Feb;33(2):2199-2211
pubmed: 30226811
Invest Ophthalmol Vis Sci. 2018 Nov 1;59(13):5671-5681
pubmed: 30489627
Invest Ophthalmol Vis Sci. 2000 Sep;41(10):3043-8
pubmed: 10967062
Invest Ophthalmol Vis Sci. 2013 Jan 30;54(1):854-63
pubmed: 23307960
Glia. 2019 May;67(5):935-949
pubmed: 30585356
Br J Ophthalmol. 2015 May;99(5):644-9
pubmed: 25359901
Biochem Biophys Res Commun. 1993 Jun 15;193(2):631-8
pubmed: 8512562
Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1599-608
pubmed: 18385080
AMA Arch Ophthalmol. 1955 Feb;53(2):211-4
pubmed: 13227683
Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10698-703
pubmed: 11526213
Cell. 2009 Oct 16;139(2):366-79
pubmed: 19837037
Int J Dev Biol. 2004;48(8-9):1045-58
pubmed: 15558494
Prog Retin Eye Res. 2010 Mar;29(2):144-68
pubmed: 20044062
Eur J Neurosci. 2006 Jun;23(11):3034-42
pubmed: 16819992
Front Immunol. 2020 Feb 21;11:39
pubmed: 32153558
Exp Eye Res. 2011 May;92(5):361-76
pubmed: 21354137
Invest Ophthalmol Vis Sci. 2015 Nov;56(12):7377-86
pubmed: 26574796
Invest Ophthalmol Vis Sci. 2014 Mar 25;55(3):1787-96
pubmed: 24458147
Genes Genet Syst. 2018 Sep 15;93(2):51-58
pubmed: 29607881
Curr Biol. 2017 Mar 6;27(5):624-637
pubmed: 28238662
Birth Defects Res C Embryo Today. 2015 Jun;105(2):87-95
pubmed: 26043871
Future Oncol. 2008 Oct;4(5):629-36
pubmed: 18922120
Pflugers Arch. 2017 Apr;469(3-4):501-515
pubmed: 28233124
Dermatol Clin. 1988 Apr;6(2):161-73
pubmed: 3288380
Development. 1992 Aug;115(4):1111-9
pubmed: 1280558
J Leukoc Biol. 2008 Sep;84(3):721-9
pubmed: 18577714
Front Immunol. 2020 May 07;11:742
pubmed: 32457740
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
J Proteome Res. 2006 Nov;5(11):3135-44
pubmed: 17081065
J Invest Dermatol. 2012 Jan;132(1):170-8
pubmed: 21850021
Am J Anat. 1971 Sep;132(1):119-32
pubmed: 4255264
Invest Ophthalmol Vis Sci. 2011 Oct 31;52(11):8458-66
pubmed: 21896849
Genesis. 2006 May;44(5):262-7
pubmed: 16676322
EMBO J. 1992 Feb;11(2):519-26
pubmed: 1537333
Eye (Lond). 2013 Feb;27(2):230-42
pubmed: 23222563
Development. 2013 May;140(10):2203-11
pubmed: 23633513
Dev Biol. 1973 May;32(1):69-81
pubmed: 4208022
Invest Ophthalmol Vis Sci. 2014 Mar 03;55(3):1313-20
pubmed: 24458151
PLoS Biol. 2016 Mar 16;14(3):e1002404
pubmed: 26981861
PLoS One. 2015 Nov 30;10(11):e0143702
pubmed: 26619124
Nat Rev Dis Primers. 2020 Apr 9;6(1):24
pubmed: 32273508
PLoS One. 2013 Aug 16;8(8):e72935
pubmed: 23977372
J Invest Dermatol. 2015 Jan;135(1):314-318
pubmed: 25075639
Prog Retin Eye Res. 2019 May;70:85-98
pubmed: 30552975
Dev Cell. 2011 Oct 18;21(4):722-34
pubmed: 21924960
Development. 2012 Jan;139(2):397-410
pubmed: 22186729
Mech Dev. 2000 Apr;92(2):135-43
pubmed: 10727853
Mol Vis. 2001 Dec 02;7:277-82
pubmed: 11740467
An Bras Dermatol. 2019 Sep - Oct;94(5):503-520
pubmed: 31777350
Am J Ophthalmol. 1972 Feb;73(2):167-82
pubmed: 4335677
Anat Rec. 1954 Sep;120(1):33-63
pubmed: 13207763
Mol Biol Cell. 2007 Oct;18(10):3914-27
pubmed: 17671165
Invest Ophthalmol Vis Sci. 2016 Dec 1;57(15):6513-6526
pubmed: 27918825
Hum Pathol. 2016 Nov;57:165-175
pubmed: 27476775
J Invest Dermatol. 2012 Nov;132(11):2610-21
pubmed: 22718121
Cancers (Basel). 2020 Apr 23;12(4):
pubmed: 32340176
Development. 2015 Feb 15;142(4):620-32
pubmed: 25670789

Auteurs

Paul G McMenamin (PG)

Department of Anatomy and Developmental Biology, School of Biomedical Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia.

Graham T Shields (GT)

Liverpool Ocular Oncology Research Group, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom.

Yashar Seyed-Razavi (Y)

Department of Anatomy and Developmental Biology, School of Biomedical Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia.

Helen Kalirai (H)

Liverpool Ocular Oncology Research Group, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom.
Liverpool Clinical Laboratories, Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom.

Robert H Insall (RH)

CRUK Beatson Institute, Bearsden, University of Glasgow, Glasgow, G61 1BD, United Kingdom.
Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom.

Laura M Machesky (LM)

CRUK Beatson Institute, Bearsden, University of Glasgow, Glasgow, G61 1BD, United Kingdom.
Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom.

Sarah E Coupland (SE)

Liverpool Ocular Oncology Research Group, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom.
Liverpool Clinical Laboratories, Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH